Find Academic Supervisors

Michael I. Miller is the Bessie Darling Massey Professor and director of the Department of Biomedical Engineering at Johns Hopkins University (JHU), where he also leads the Center for Imaging Science and co-directs the Kavli Neuroscience Discovery Institute. His work focuses on computational medicine, medical imaging, and computational anatomy, particularly in neurodegenerative diseases like Alzheimer’s, Huntington’s, and schizophrenia. Miller has pioneered cloud-based methods for brain image libraries and algorithms, co-founded four startups, and holds over 200 publications and two textbooks. He earned his BS from SUNY Stony Brook (1976) and MS/PhD from JHU (1978/1983). Education: Bachelor of Science, State University of New York at Stony Brook, 1976 Master of Science, Johns Hopkins University, 1978 Doctor of Philosophy, Johns Hopkins University, 1983 Research Interests: Miller’s research integrates advanced imaging technologies to study brain structure and function in health/disease. Key areas include: Functional and structural analysis of neurodegenerative diseases Development of computational tools for early disease detection Multiscale data integration (molecular to tissue) Translational applications in clinical diagnostics Awards: IEEE Biomedical Engineering Thesis Award (1982) Johns Hopkins Paul Ehrlich Thesis Award (1983) NSF Presidential Young Investigator Award (1986) Johns Hopkins Gilman Scholar (2011) Fellow, American Institute for Medical and Biological Engineering Labs/Teams: His lab at JHU develops cloud-based imaging tools and collaborates on translational research. Projects include the xIV-LDDMM Toolkit and STalign spatial transcriptomics alignment software.

• Medical Imaging
• Computational Anatomy
• Pattern Theory
• +3 more

Professor Kamil Ekinci is a faculty member in the Department of Mechanical Engineering at Boston University, with additional affiliations in Materials Science & Engineering and the Photonics Center. He holds a PhD from Brown University and specializes in nanoscale phenomena, including nanomechanics, nanofluidics, and nanophotonics. His research integrates advanced nanofabrication and ultrasensitive measurement techniques to study fundamental physical and biological processes. His research group explores applications in biotechnology, such as developing ultrasensitive measurement tools for antibiotic susceptibility testing and cardiac tissue engineering. Notable achievements include the NSF CAREER Award (2007) and pioneering work on nanofluidic systems. Collaborations span disciplines, including the School of Medicine and institutions like Argonne National Laboratory. Recent projects focus on transitional fluid dynamics, optomechanical transducers, and bacterial movement analysis. The group maintains labs in the Photonics Center and actively seeks graduate students and postdocs in NEMS and related fields.

• Nanomechanics
• Nanofluidics
• Nanophotonics
• +4 more

Evan Biederstedt is an Associate in Biomedical Informatics at Harvard Medical School, affiliated with the Gehlenborg Lab. He holds a Master of Science (MSc) and specializes in computational biology with a focus on cancer genomics. His work includes developing the Cell Annotation Platform (CAP) to enhance cellular state interpretation through metadata and molecular signature analysis. Biederstedt’s research spans single-cell analysis, spatial transcriptomics, and genomic tools for structural variant discovery. His contributions include scaling cross-tissue annotation models and haplotype-aware somatic variation analysis. Key areas of focus include bioinformatics tool development, cancer genomics, and genomic data integration. He has collaborated on projects like the Virus Discovery Codeathon and international hackathons for genomic analysis. Biederstedt’s GitHub profile showcases his open-source contributions. His publications highlight advancements in tensor decomposition for patient cohort analysis, spatial transcriptomics, and pangenome strategies. Biederstedt’s work bridges computational methods with biomedical applications, emphasizing scalable solutions for complex genomic data challenges.

• Computational Biology
• Cancer Genomics
• Bioinformatics
• +3 more

Mark S. Humayun is a University Professor at the University of Southern California (USC), holding joint appointments in the Keck School of Medicine and the Viterbi School of Engineering. He serves as Director of the USC Ginsburg Institute for Biomedical Therapeutics and Co-Director of the USC Roski Eye Institute. His expertise lies at the intersection of ophthalmology, biomedical engineering, and stem cell biology. Humayun earned his MD from Duke University and PhD from the University of North Carolina, Chapel Hill. He pioneered the Argus II retinal implant, the first FDA-approved bionic eye for restoring vision in the blind, for which he received the National Medal of Technology and Innovation (2016). His research focuses on retinal prosthetics, stem cell therapies, and non-invasive neurostimulation techniques. Key contributions include advancements in ultrasound-based vision restoration and bioengineered retinal implants. Humayun has over 300 publications and 140 patents, with awards such as the IEEE Medal for Innovations in Healthcare Technology (2020) and ARVO Fellow (2022). His work bridges clinical practice and engineering, addressing retinal degeneration and macular diseases through innovative technologies. Notable achievements include leading the development of the Argus II, which has restored partial vision to patients with retinitis pigmentosa. Current research explores next-generation implants, stem cell-derived RPE therapies, and ultrasonic stimulation for broader vision restoration. His interdisciplinary teams collaborate across engineering, computer science, and medicine to tackle complex ophthalmic challenges.

• Ophthalmology
• Biomedical Engineering
• Stem Cell Biology
• +5 more

Dr. Steve Kay is a University and Provost Professor of Neurology, Cancer Biology, Biomedical Engineering, and Biological Sciences at the Keck School of Medicine of USC. He holds the David L. Lee and Simon Ramo Chair in Health Science and Technology and serves as Director of the MESH Academy and USC Michelson Center for Convergent Bioscience. Previously, he was Dean of USC Dornsife College (2012–2015) and President of The Scripps Research Institute (2015–2016). His research focuses on circadian rhythms, plant genetics, and their applications in cancer therapy and drug development. Education: PhD and DSc from the University of Bristol, UK Research Interests: Circadian rhythms are central to Dr. Kay’s work, exploring their role in health, disease, and cancer. He investigates how genetic and environmental factors influence biological clocks, with applications in developing targeted therapies for glioblastoma and other cancers. His lab also studies plant circadian mechanisms, particularly nitrate transport and stress responses. Publications: His 200+ papers span circadian biology, cancer, and plant science. Recent work highlights circadian-based therapies, clock protein modulators, and the role of BMAL1 in hepatocellular carcinoma. Awards: National Academy of Sciences Member (2008) AAAS Fellow (2009) Martin Gibbs Medal (2011) Thomson Reuters’ Most Influential Scientific Minds (2014–2017) Grants & Labs: He leads the Kay Laboratory at USC, focusing on translational research. His work bridges academia and industry, founding biotech companies to advance circadian medicine.

• Circadian Rhythms
• Cancer Biology
• Genetics
• +4 more

Daniel S. Oh, MD is a Clinical Associate Professor of Surgery (Practitioner) at the Keck School of Medicine of the University of Southern California, specializing in general thoracic surgery with a focus on minimally invasive and robotic techniques. He serves as the medical director at the USC-St. Jude Center for Thoracic and Esophageal Diseases in Fullerton, where he sees patients exclusively. Dr. Oh has extensive experience in robotic-assisted thoracic procedures, with approximately 90 percent of his major operations performed using robotic assistance since 2011. Medical Degree: Not specified in text Surgical Training: USC and Harvard Medical School (Brigham and Women's Hospital) Dr. Oh's research interests center on advancing robotic surgical techniques, particularly in thoracic and esophageal procedures. He actively collaborates with Intuitive Surgical to improve robotic technology, surgical training methods, and develop new procedures that enhance patient outcomes. His work emphasizes a disease-specific rather than technology-specific approach, making him unique among thoracic surgeons as he also performs advanced endoscopic and bronchoscopic procedures. Analysis of Dr. Oh's recent publications reveals a strong focus on objective performance metrics in robotic surgery, surgical education methodologies, and optimizing robotic-assisted thoracic procedures. His research spans both clinical outcomes and technological innovations, with particular attention to quantifying surgical skill, workflow efficiency, and the learning curve associated with robotic techniques. The publications demonstrate a consistent trajectory toward establishing evidence-based standards for robotic surgical training and performance assessment. Dr. Oh is a strong advocate for multidisciplinary care, working closely with colleagues in gastroenterology, pulmonology, medical oncology, radiation oncology, radiology, and pathology to provide comprehensive, patient-tailored treatment. His clinical philosophy emphasizes a team-based approach to achieve optimal outcomes for patients with complex thoracic conditions.

• Thoracic Surgery
• Robotic Surgery
• Minimally Invasive Surgery
• +7 more

Walter O’Dell is an Associate Professor in the Department of Radiation Oncology at the University of Florida. His research focuses on developing novel image analysis and computational techniques to improve cancer detection, treatment follow-up, and therapy, particularly in stereotactic body radiation therapy (SBRT). The O’Dell Lab emphasizes translational research with direct clinical applications in patient care, alongside animal and in-vitro studies to validate findings. Key research areas include 3D tumor detection for lung, brain, and breast cancers; finite element modeling for needle biopsy deformation analysis; and quantitative CT imaging to assess radiation-induced tissue damage. Additionally, the lab explores MRI techniques such as diffusion-weighted imaging and spectroscopy for modeling tumor spread in brain cancers, as well as cardiac MRI tagging to study chemotherapy and radiation effects on long-term cancer survivors’ hearts. His work bridges engineering and medicine, aiming to enhance treatment precision and patient outcomes through advanced imaging technologies. The lab’s efforts include potential applications in drug development for protecting healthy tissues during radiation therapy.

• Medical Imaging
• Radiation Oncology
• Biomedical Engineering
• +3 more

Young Jin Lee is a Professor of Chemistry at Iowa State University , Ames, IA. His research focuses on advancing mass spectrometry imaging (MSI) technologies, particularly matrix-assisted laser desorption/ionization (MALDI), to address biological and forensic challenges. Key areas include spatial metabolomics, on-tissue chemical derivatization (OTCD), in vivo isotope labeling, and applications in plant systems and clinical diagnostics. Research interests span plant metabolomics , forensic fingerprint analysis , and rapid antibiotic resistance testing . Notable methodologies include OzMALDI for double-bond assignment and multiplex MALDI-MS imaging for latent fingerprint profiling. His lab develops novel instrumentation, such as mobilized electrospray devices and nanoparticle-based substrates, to enhance analytical sensitivity and spatial resolution. Forensic applications highlight predicting fingerprint age via ozonolysis kinetics and linking triacylglycerol profiles to individual lifestyle markers. In plant biology, studies investigate galactolipid biosynthesis in duckweed and maize root metabolism using isotopic tracing. The group also explores 3D MALDI-MSI for single-cell metabolomics in plant and zebrafish embryos. Instrumentation innovations include high-resolution MALDI-MS systems and open-source tools like rMSIcleanup for matrix peak annotation. Collaborative work extends to microbiome metabolomics and pyrolysis analysis of biomass. Labs/Teams: Lee Laboratory (Iowa State University). Research is supported by grants focusing on analytical chemistry, forensic science, and plant biology applications.

• Mass Spectrometry Imaging
• Metabolomics
• Forensic Science
• +3 more

Solaiman Tarafder is an Assistant Professor in the Department of Mechanical Engineering at South Dakota State University (SDSU), Brookings. His research focuses on bioadhesives, stimuli-responsive biomaterials, immunomodulatory materials, and advanced manufacturing techniques for musculoskeletal tissue regeneration. He holds a Ph.D. in Materials Science and Engineering from Washington State University and has held prior roles at Columbia University and the Shu-Tung and Alice Li Foundation. Education: B.S. and M.S. in Chemistry, Shahjalal University of Science and Technology, Bangladesh Ph.D. in Materials Science and Engineering, Washington State University Research Interests: 3D printing of bioscaffolds for bone, tendon, and cartilage regeneration Design of bioactive adhesives and drug delivery systems Immunomodulation strategies for joint preservation Spatiotemporal control of bioactive cues for stem cell differentiation Awards: Associate Research Scientist Mentor of the Year (2019) Outstanding Teaching Assistant (2012) Materials Science and Technology Conference First Place Poster (2012) Grants: $10,000 grant from Columbia University (2019) for immunomodulatory systems in cartilage regeneration Labs/Teams: Tarafder Lab at SDSU focusing on biomaterials and tissue engineering

• Bioadhesives
• Stimuli-Responsive Biomaterials
• Immunomodulatory Biomaterials
• +5 more

Minju Kim is a Professor in the Korean Department within the School of Modern Languages and Literatures. She holds significant academic and editorial roles, including President of the International Circle of Korean Linguistics (ICKL) and Editor-in-Chief of The Korean Language in America . Her expertise spans Pragmatics, Grammaticalization, Discourse Analysis, Language and Gender, and Language Education. She earned her B.A. and M.A. from Yonsei University and her Ph.D. from the University of California, Los Angeles (UCLA). Dr. Kim’s research focuses on Korean linguistic structures, including honorifics, stance markers, and historical grammaticalization processes. Notable contributions include studies on Korean connectives, modal particles, and gendered language use in media. She has received the Korea Foundation Field Research Grant (2025). Her publications reflect interdisciplinary engagement in linguistics and sociolinguistics, with recent work addressing topics like Korean semi-honorific styles and cross-linguistic comparisons. She actively contributes to academic discourse through editorial roles and international collaborations.

• Pragmatics
• Grammaticalization
• Discourse Analysis
• +2 more

Michael Lane, PhD, is an Associate Professor in the Department of Neurobiology & Anatomy at Drexel University College of Medicine. He leads a research team focused on spinal cord injury (SCI), particularly cervical SCI and its impact on respiratory and motor functions. His work emphasizes neural plasticity, cell transplantation therapies, and rehabilitative strategies to enhance functional recovery. Prior to Drexel, he held positions at the University of Florida and served as a lecturer at The Ohio State University. Education: PhD in Pharmacology (University of Melbourne, 2004); BSc in Anatomy and Physiology (University of Tasmania, 1999, summa cum laude). Research Interests: Spinal cord injury recovery, neural plasticity mechanisms, cell-based therapies (e.g., neural progenitor transplants), respiratory function restoration, and activity-based rehabilitation. Key projects include NIH-funded studies on respiratory training and neural transplants. Awards: Includes the Molly and Bernard Sandberg Award (2019), Best Mentor Award (2017), and election as President of the American Society for Neural Therapy and Repair (2022). Grants: Current funding includes projects on respiratory training (Pennsylvania Department of Health, 2021-2023), neural transplants (NIH NINDS R01, 2018-2023), and stem cell-derived neural progenitors (Moseley Foundation, 2019-2022). Lane Lab: Focuses on preclinical research to bridge discovery and clinical application, emphasizing strategies like cell transplantation and activity-based therapies to improve post-SCI outcomes.

• Spinal Cord Injury
• Neural Plasticity
• Cell Therapy
• +4 more

Dr. Blanche Young is an Assistant Professor and co-director of the Interdepartmental Medical Science (IMS) program at Drexel University's Graduate School of Biomedical Sciences and Professional Studies. She holds a full-time faculty position with teaching responsibilities across multiple programs, including the IMS and Evening Post-Baccalaureate Premedical (PMED) programs. Education: BA from University of Hawaii at Manoa PhD from Tufts University Research Focus: Her interdisciplinary work spans developmental biology, molecular oncology, and tissue morphogenesis, with emphasis on signaling pathways (hedgehog, Wnt), collagen biology in corneal/tendon tissues, and breast cancer mechanisms. She also investigates skeletal development and extracellular matrix dynamics. Publications Overview: Her research outputs (2000-2008) predominantly explore skeletal and cartilage development, collagen functions in connective tissues, and molecular regulation of morphogenesis. Key themes include progenitor cell dynamics, hedgehog signaling in cranial development, and fibrillogenesis mechanisms across tendon/corneal systems. Teaching & Leadership: Developed 'Fundamentals of Cancer Biology' course integrating disease models Teaches Microanatomy Lab, Medicine and Society, and General Biology Co-directs IMS program operations and curriculum

• Developmental Biology
• Cancer Biology
• Molecular Biology
• +3 more

Steven Carroll, MD, PhD, is a Professor and Chair of the Department of Pathology and Laboratory Medicine at the Medical University of South Carolina (MUSC). He holds the Gordon R. Hennigar, Jr., MD Endowed Chair in Pathology and directs the Biorepository & Tissue Analysis Shared Resource at MUSC Hollings Cancer Center, the South Carolina Alzheimer’s Disease Research Center, and the Carroll A. Campbell Jr. Neuropathology Laboratory. His research focuses on neurofibromatosis type 1 (NF1), malignant peripheral nerve sheath tumors (MPNSTs), and neurodegenerative diseases. BS in Vertebrate Zoology, Chemistry, and Anthropology, University of Memphis (1981) MD and PhD in Cell Biology, Baylor College of Medicine (1986-1988) Postdoctoral training in Anatomic Pathology and Neuropathology at Washington University in St. Louis (1988-1994) His research program investigates growth factor signaling in MPNST pathogenesis, particularly neuregulin-1 (NRG1) and erbB receptors . He explores genetic and epigenetic mechanisms of tumor progression and neurodegeneration, with a focus on R-Ras subfamily proteins and lysophosphatidic acid receptors . His work employs genetically engineered mouse models and human biospecimen networks for translational studies. Recent publications highlight his expertise in MPNST mouse models (2024), cross-species genomic analysis (2023), and ERBB3's role in oncogenesis (2019). Collaborations include the international Down Syndrome Biobanking Consortium and national biospecimen networks . Scientific Awards: Fellow of the American Society of Clinical Pathologists (FASCP) Fellow of the College of American Pathologists (FCAP) Dr. Carroll has been continuously funded by the National Institutes of Health (NIH) and Department of Defense (DoD) since 2001. He serves as Associate Editor for the American Journal of Pathology and Journal of Neuropathology and Experimental Neurology , and on the editorial board of Neuro-Oncology . His lab has developed key platforms for neurofibromatosis research and Alzheimer's disease proteomics .

• Neurofibromatosis Type 1 (NF1)
• Malignant Peripheral Nerve Sheath Tumors (MPNSTs)
• Neurodegenerative Diseases
• +2 more

Junping Shi is a Professor in the Department of Mathematics at the College of William & Mary, where he has held academic positions since 2000, including serving as Department Chair from 2018 to 2022. He earned his undergraduate degree from Nankai University (1990–1993) and a Ph.D. from Brigham Young University (1998). His research focuses on partial differential equations, dynamical systems, and mathematical biology, with applications in pattern formation, population dynamics, and ecological modeling. Shi's academic work emphasizes the analysis of reaction-diffusion equations, bifurcation theory, and nonlocal models in biological systems. His recent studies include tumor growth modeling, spatial movement with memory effects, and phytoplankton-virus interactions. He has contributed to understanding pattern formation in aquatic and terrestrial ecosystems, including marsh vegetation dynamics and predator-prey interactions. His research spans theoretical analysis (e.g., stability, bifurcation, and well-posedness) and applied models in ecology and epidemiology. Notable applications include modeling blue crab population dynamics in Chesapeake Bay and the biodegradation of organic matter influenced by bacterivorous grazing. Shi frequently explores the interplay between spatial heterogeneity, temporal delays, and nonlinear interactions in biological systems.

• Partial Differential Equations
• Dynamical Systems
• Mathematical Biology
• +4 more

Summer L. Gibbs is a Professor and the Douglas Strain Endowed Professor of Biomedical Engineering at Oregon Health and Science University (OHSU). She specializes in developing novel contrast agents and imaging technologies for clinical translation, with a focus on nerve-specific fluorescence imaging and theranostic applications. Education: B.S., 2003, Whitworth College Ph.D., 2008, Dartmouth College (Thayer School of Engineering) Postdoctoral Fellow at Harvard Medical School and Beth Israel Deaconess Medical Center Research Interests: Her lab develops nerve-specific fluorophores (e.g., near-infrared agents) to improve surgical precision and reduce nerve injury. She also pioneers cyclic immunostaining (cyCIF) for multiplex microscopy, enabling spatial analysis of cancer phenotypes and treatment efficacy. Recent work includes imaging tumor margins, drug distribution, and hybrid cancer-immune cells as metastasis biomarkers. Labs/Teams: Her interdisciplinary team collaborates across biomedical engineering, oncology, and surgery to advance translational imaging tools for clinical use.

• Nerve-Specific Fluorophores
• Image-Guided Surgery
• Cyclic Immunostaining
• +3 more